Share Price and Basic Stock Data
Last Updated: December 24, 2025, 4:16 am
| PEG Ratio | 0.00 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Diamines & Chemicals Ltd operates in the specialty chemicals sector, focusing on producing a variety of chemical products. The company’s revenue has seen considerable fluctuations over the past year, with sales peaking at ₹35.69 Cr in March 2023 before dropping to ₹19.92 Cr in September 2023. The most recent quarterly sales for December 2023 stood at ₹23.03 Cr, suggesting some recovery but still below the peak levels. Overall, the fiscal year ending March 2025 recorded sales of ₹71.41 Cr, a decline from the ₹110.34 Cr reported for March 2023. This decline raises concerns about the company’s ability to sustain its revenue growth. While the business has shown resilience, the volatility in sales could be attributed to changing market demands and competitive pressures, indicating a need for strategic adjustments to stabilize and grow revenue consistently.
Profitability and Efficiency Metrics
Profitability has been a significant challenge for Diamines & Chemicals, as evidenced by its operating profit margin (OPM) which stood at a concerning -32.24% for the year ending March 2025. The company’s net profit also reflects this struggle, with a reported figure of ₹2.73 Cr for March 2025, a stark decrease from ₹41.90 Cr in March 2023. The interest coverage ratio, although strong at 25.34x, suggests that the company can comfortably cover its interest obligations, yet this does not compensate for the declining profitability metrics. Furthermore, the return on equity (ROE) and return on capital employed (ROCE) are low at 1.78% and 3.33%, respectively, indicating inefficiencies in generating returns from shareholders’ equity and capital. The declining profitability amidst high operational costs raises questions about the company’s operational efficiency and pricing power in a competitive landscape.
Balance Sheet Strength and Financial Ratios
Diamines & Chemicals appears to have a relatively strong balance sheet, with total reserves increasing to ₹144.43 Cr as of March 2025, up from ₹124.74 Cr a year earlier. This growth in reserves suggests a buffer against volatility and potential investment in future growth. The company maintains low borrowings at ₹9.81 Cr, which contributes to a strong current ratio of 7.36, indicating good short-term liquidity. However, the price-to-book value ratio of 1.90x suggests that the market may be valuing the company’s equity at a premium relative to its book value, which could be a double-edged sword. While a high P/BV can indicate strong growth expectations, it may also signal overvaluation risks if the company fails to meet those expectations in the coming periods.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Diamines & Chemicals shows a stable promoter holding of 55.21%, which can instill confidence among retail investors. However, foreign institutional investors (FIIs) have not shown significant interest, holding only 0.00%, while domestic institutional investors (DIIs) account for a mere 0.02%. This lack of institutional backing may reflect broader market skepticism regarding the company’s growth prospects. The total number of shareholders has slightly declined from 13,794 in March 2025 to 13,363, indicating potential disenchantment among retail investors. The modest public holding of 44.77% also suggests that the stock may not be attracting new investors, which could hinder price appreciation and market confidence.
Outlook, Risks, and Final Insight
Looking ahead, Diamines & Chemicals faces a mixed outlook. On one hand, its strong balance sheet and low debt levels provide a solid foundation for potential recovery. On the other hand, the significant drop in profitability and sales volatility pose substantial risks. The company must focus on improving operational efficiencies and possibly reevaluating its product pricing strategies to regain lost margins. Additionally, the lack of institutional interest could hinder stock performance, making it crucial for the company to communicate a clear growth strategy to attract new investors. Retail investors might consider the stock as a speculative play, balancing the potential for recovery against the risks of continued underperformance in profitability and market confidence.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Diamines & Chemicals Ltd | 256 Cr. | 261 | 515/250 | 158 | 0.38 % | 3.33 % | 1.78 % | 10.0 | |
| Deco-Mica Ltd | 31.1 Cr. | 74.0 | 90.0/56.0 | 17.0 | 64.2 | 0.00 % | 11.8 % | 7.51 % | 10.0 |
| Andhra Sugars Ltd | 1,026 Cr. | 75.7 | 100/64.9 | 12.8 | 121 | 1.05 % | 3.54 % | 2.51 % | 2.00 |
| Tamil Nadu Petro Products Ltd | 948 Cr. | 105 | 130/63.6 | 9.48 | 109 | 1.14 % | 6.97 % | 5.10 % | 10.0 |
| SRF Ltd | 91,987 Cr. | 3,103 | 3,325/2,197 | 56.9 | 447 | 0.23 % | 12.3 % | 10.4 % | 10.0 |
| Industry Average | 14,736.00 Cr | 1,177.90 | 33.43 | 204.33 | 0.41% | 10.57% | 8.89% | 7.60 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 23.02 | 26.98 | 24.87 | 35.69 | 31.70 | 19.92 | 23.03 | 29.38 | 16.84 | 19.19 | 17.51 | 17.93 | 12.25 |
| Expenses | 8.33 | 10.61 | 12.75 | 23.32 | 22.11 | 14.93 | 18.31 | 26.00 | 18.20 | 15.58 | 15.99 | 16.24 | 16.20 |
| Operating Profit | 14.69 | 16.37 | 12.12 | 12.37 | 9.59 | 4.99 | 4.72 | 3.38 | -1.36 | 3.61 | 1.52 | 1.69 | -3.95 |
| OPM % | 63.81% | 60.67% | 48.73% | 34.66% | 30.25% | 25.05% | 20.50% | 11.50% | -8.08% | 18.81% | 8.68% | 9.43% | -32.24% |
| Other Income | 0.56 | 0.66 | 0.54 | 0.98 | 0.70 | 0.61 | 0.58 | 0.66 | 0.66 | 0.81 | 0.77 | 0.93 | 1.89 |
| Interest | 0.04 | 0.02 | 0.04 | 0.05 | 0.04 | 0.04 | 0.13 | -0.01 | 0.03 | 0.06 | 0.17 | 0.09 | 0.01 |
| Depreciation | 0.42 | 0.44 | 0.45 | 0.47 | 0.50 | 0.69 | 0.94 | 0.73 | 0.86 | 0.88 | 0.88 | 0.87 | 0.89 |
| Profit before tax | 14.79 | 16.57 | 12.17 | 12.83 | 9.75 | 4.87 | 4.23 | 3.32 | -1.59 | 3.48 | 1.24 | 1.66 | -2.96 |
| Tax % | 25.49% | 25.29% | 26.54% | 25.33% | 28.21% | 23.61% | 30.50% | 33.43% | 6.92% | 27.30% | 34.68% | 20.48% | -7.43% |
| Net Profit | 11.02 | 12.37 | 8.93 | 9.57 | 7.01 | 3.41 | 2.80 | 2.25 | -1.75 | 2.46 | 0.75 | 1.26 | -2.81 |
| EPS in Rs | 11.26 | 12.64 | 9.13 | 9.78 | 7.17 | 3.49 | 2.86 | 2.30 | -1.79 | 2.51 | 0.77 | 1.29 | -2.87 |
Last Updated: August 19, 2025, 8:00 pm
Below is a detailed analysis of the quarterly data for Diamines & Chemicals Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 12.25 Cr.. The value appears to be declining and may need further review. It has decreased from 17.93 Cr. (Mar 2025) to 12.25 Cr., marking a decrease of 5.68 Cr..
- For Expenses, as of Jun 2025, the value is 16.20 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 16.24 Cr. (Mar 2025) to 16.20 Cr., marking a decrease of 0.04 Cr..
- For Operating Profit, as of Jun 2025, the value is -3.95 Cr.. The value appears to be declining and may need further review. It has decreased from 1.69 Cr. (Mar 2025) to -3.95 Cr., marking a decrease of 5.64 Cr..
- For OPM %, as of Jun 2025, the value is -32.24%. The value appears to be declining and may need further review. It has decreased from 9.43% (Mar 2025) to -32.24%, marking a decrease of 41.67%.
- For Other Income, as of Jun 2025, the value is 1.89 Cr.. The value appears strong and on an upward trend. It has increased from 0.93 Cr. (Mar 2025) to 1.89 Cr., marking an increase of 0.96 Cr..
- For Interest, as of Jun 2025, the value is 0.01 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.09 Cr. (Mar 2025) to 0.01 Cr., marking a decrease of 0.08 Cr..
- For Depreciation, as of Jun 2025, the value is 0.89 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.87 Cr. (Mar 2025) to 0.89 Cr., marking an increase of 0.02 Cr..
- For Profit before tax, as of Jun 2025, the value is -2.96 Cr.. The value appears to be declining and may need further review. It has decreased from 1.66 Cr. (Mar 2025) to -2.96 Cr., marking a decrease of 4.62 Cr..
- For Tax %, as of Jun 2025, the value is -7.43%. The value appears to be improving (decreasing) as expected. It has decreased from 20.48% (Mar 2025) to -7.43%, marking a decrease of 27.91%.
- For Net Profit, as of Jun 2025, the value is -2.81 Cr.. The value appears to be declining and may need further review. It has decreased from 1.26 Cr. (Mar 2025) to -2.81 Cr., marking a decrease of 4.07 Cr..
- For EPS in Rs, as of Jun 2025, the value is -2.87. The value appears to be declining and may need further review. It has decreased from 1.29 (Mar 2025) to -2.87, marking a decrease of 4.16.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:51 am
| Metric | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 66.86 | 57.40 | 43.94 | 39.09 | 35.58 | 62.82 | 65.97 | 110.34 | 103.97 | 71.41 | 56.99 |
| Expenses | 56.54 | 49.64 | 38.12 | 34.16 | 31.12 | 37.20 | 43.90 | 54.72 | 81.29 | 65.95 | 61.62 |
| Operating Profit | 10.32 | 7.76 | 5.82 | 4.93 | 4.46 | 25.62 | 22.07 | 55.62 | 22.68 | 5.46 | -4.63 |
| OPM % | 15.44% | 13.52% | 13.25% | 12.61% | 12.54% | 40.78% | 33.45% | 50.41% | 21.81% | 7.65% | -8.12% |
| Other Income | 0.38 | 0.23 | 0.30 | 0.18 | 0.36 | 2.05 | 1.79 | 2.65 | 2.56 | 3.15 | 4.20 |
| Interest | 3.59 | 3.81 | 3.26 | 3.41 | 2.75 | 0.08 | 0.09 | 0.14 | 0.20 | 0.34 | 0.34 |
| Depreciation | 2.16 | 2.39 | 2.43 | 2.03 | 1.99 | 1.79 | 1.67 | 1.78 | 2.85 | 3.49 | 3.60 |
| Profit before tax | 4.95 | 1.79 | 0.43 | -0.33 | 0.08 | 25.80 | 22.10 | 56.35 | 22.19 | 4.78 | -4.37 |
| Tax % | 28.89% | 25.14% | 9.30% | 378.79% | -212.50% | 18.64% | 24.34% | 25.64% | 28.39% | 38.08% | |
| Net Profit | 3.52 | 1.35 | 0.39 | -1.59 | 0.25 | 20.99 | 16.71 | 41.90 | 15.47 | 2.73 | -4.95 |
| EPS in Rs | 3.60 | 1.38 | 0.40 | -1.63 | 0.26 | 21.46 | 17.08 | 42.83 | 15.81 | 2.79 | -5.05 |
| Dividend Payout % | 27.78% | 3.62% | 0.00% | 0.00% | 0.00% | 23.30% | 17.56% | 7.00% | 15.80% | 35.82% |
YoY Net Profit Growth
| Year | 2012-2013 | 2013-2014 | 2014-2015 | 2015-2016 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -61.65% | -71.11% | -507.69% | 115.72% | -20.39% | 150.75% | -63.08% | -82.35% |
| Change in YoY Net Profit Growth (%) | 0.00% | -9.46% | -436.58% | 623.42% | -136.11% | 171.14% | -213.83% | -19.27% |
Diamines & Chemicals Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 8 years from 2012-2013 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | % |
| 3 Years: | 3% |
| TTM: | -25% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | % |
| 3 Years: | -45% |
| TTM: | -75% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | -5% |
| 3 Years: | -8% |
| 1 Year: | -33% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 15% |
| Last Year: | 2% |
Last Updated: September 5, 2025, 3:16 pm
Balance Sheet
Last Updated: December 4, 2025, 2:45 am
| Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 | 9.78 |
| Reserves | 23.57 | 24.25 | 24.54 | 22.75 | 23.00 | 75.20 | 90.41 | 124.74 | 138.33 | 151.47 | 144.43 |
| Borrowings | 26.34 | 19.53 | 19.75 | 20.10 | 15.56 | 0.30 | 0.00 | 0.00 | 0.00 | 0.03 | 9.81 |
| Other Liabilities | 14.85 | 12.90 | 10.47 | 10.05 | 8.64 | 9.50 | 10.36 | 16.56 | 14.56 | 16.81 | 13.48 |
| Total Liabilities | 74.54 | 66.46 | 64.54 | 62.68 | 56.98 | 94.78 | 110.55 | 151.08 | 162.67 | 178.09 | 177.50 |
| Fixed Assets | 34.51 | 33.23 | 31.51 | 29.30 | 27.33 | 22.47 | 37.55 | 40.06 | 65.38 | 63.79 | 64.98 |
| CWIP | 1.13 | 1.51 | 1.17 | 1.17 | 1.20 | 0.15 | 1.88 | 21.39 | 0.83 | 2.26 | 13.14 |
| Investments | 0.10 | 0.10 | 0.10 | 0.10 | 0.08 | 5.94 | 12.67 | 13.30 | 15.76 | 16.07 | 12.29 |
| Other Assets | 38.80 | 31.62 | 31.76 | 32.11 | 28.37 | 66.22 | 58.45 | 76.33 | 80.70 | 95.97 | 87.09 |
| Total Assets | 74.54 | 66.46 | 64.54 | 62.68 | 56.98 | 94.78 | 110.55 | 151.08 | 162.67 | 178.09 | 177.50 |
Below is a detailed analysis of the balance sheet data for Diamines & Chemicals Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 9.78 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 9.78 Cr..
- For Reserves, as of Sep 2025, the value is 144.43 Cr.. The value appears to be declining and may need further review. It has decreased from 151.47 Cr. (Mar 2025) to 144.43 Cr., marking a decrease of 7.04 Cr..
- For Borrowings, as of Sep 2025, the value is 9.81 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 0.03 Cr. (Mar 2025) to 9.81 Cr., marking an increase of 9.78 Cr..
- For Other Liabilities, as of Sep 2025, the value is 13.48 Cr.. The value appears to be improving (decreasing). It has decreased from 16.81 Cr. (Mar 2025) to 13.48 Cr., marking a decrease of 3.33 Cr..
- For Total Liabilities, as of Sep 2025, the value is 177.50 Cr.. The value appears to be improving (decreasing). It has decreased from 178.09 Cr. (Mar 2025) to 177.50 Cr., marking a decrease of 0.59 Cr..
- For Fixed Assets, as of Sep 2025, the value is 64.98 Cr.. The value appears strong and on an upward trend. It has increased from 63.79 Cr. (Mar 2025) to 64.98 Cr., marking an increase of 1.19 Cr..
- For CWIP, as of Sep 2025, the value is 13.14 Cr.. The value appears strong and on an upward trend. It has increased from 2.26 Cr. (Mar 2025) to 13.14 Cr., marking an increase of 10.88 Cr..
- For Investments, as of Sep 2025, the value is 12.29 Cr.. The value appears to be declining and may need further review. It has decreased from 16.07 Cr. (Mar 2025) to 12.29 Cr., marking a decrease of 3.78 Cr..
- For Other Assets, as of Sep 2025, the value is 87.09 Cr.. The value appears to be declining and may need further review. It has decreased from 95.97 Cr. (Mar 2025) to 87.09 Cr., marking a decrease of 8.88 Cr..
- For Total Assets, as of Sep 2025, the value is 177.50 Cr.. The value appears to be declining and may need further review. It has decreased from 178.09 Cr. (Mar 2025) to 177.50 Cr., marking a decrease of 0.59 Cr..
Notably, the Reserves (144.43 Cr.) exceed the Borrowings (9.81 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -16.02 | -11.77 | -13.93 | -15.17 | -11.10 | 25.32 | 22.07 | 55.62 | 22.68 | 5.43 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 56.50 | 65.75 | 67.04 | 72.74 | 75.71 | 54.79 | 55.44 | 75.72 | 58.63 | 70.74 |
| Inventory Days | 177.56 | 122.26 | 184.13 | 184.33 | 155.05 | 283.59 | 43.30 | 233.57 | 135.42 | 335.64 |
| Days Payable | 71.12 | 58.50 | 66.67 | 52.30 | 34.46 | 64.90 | 44.80 | 104.92 | 40.49 | 93.05 |
| Cash Conversion Cycle | 162.95 | 129.52 | 184.50 | 204.77 | 196.31 | 273.47 | 53.93 | 204.37 | 153.56 | 313.33 |
| Working Capital Days | -1.31 | -13.93 | 10.88 | 32.12 | 25.54 | 102.61 | 39.61 | 96.39 | 94.37 | 184.52 |
| ROCE % | 9.89% | 6.86% | 5.77% | 5.61% | 23.96% | 48.22% | 15.78% | 3.33% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 2.79 | 16.24 | 42.84 | 17.08 | 21.46 |
| Diluted EPS (Rs.) | 2.79 | 16.23 | 42.80 | 17.08 | 21.46 |
| Cash EPS (Rs.) | 6.59 | 19.15 | 44.66 | 18.79 | 23.29 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 164.82 | 151.38 | 137.51 | 102.41 | 86.87 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 164.82 | 151.38 | 137.51 | 102.41 | 86.87 |
| Revenue From Operations / Share (Rs.) | 73.05 | 106.33 | 113.01 | 67.57 | 64.21 |
| PBDIT / Share (Rs.) | 8.80 | 25.79 | 59.57 | 24.38 | 28.28 |
| PBIT / Share (Rs.) | 5.23 | 22.88 | 57.75 | 22.67 | 26.45 |
| PBT / Share (Rs.) | 4.88 | 22.68 | 57.60 | 22.59 | 26.38 |
| Net Profit / Share (Rs.) | 3.02 | 16.24 | 42.84 | 17.08 | 21.46 |
| NP After MI And SOA / Share (Rs.) | 2.79 | 15.81 | 42.83 | 17.08 | 21.46 |
| PBDIT Margin (%) | 12.04 | 24.25 | 52.71 | 36.07 | 44.04 |
| PBIT Margin (%) | 7.16 | 21.51 | 51.09 | 33.55 | 41.19 |
| PBT Margin (%) | 6.68 | 21.33 | 50.96 | 33.42 | 41.07 |
| Net Profit Margin (%) | 4.13 | 15.27 | 37.90 | 25.28 | 33.42 |
| NP After MI And SOA Margin (%) | 3.82 | 14.87 | 37.90 | 25.28 | 33.42 |
| Return on Networth / Equity (%) | 1.69 | 10.44 | 31.14 | 16.68 | 24.70 |
| Return on Capital Employeed (%) | 3.08 | 14.69 | 40.81 | 21.30 | 29.10 |
| Return On Assets (%) | 1.53 | 9.51 | 27.73 | 15.11 | 22.15 |
| Asset Turnover Ratio (%) | 0.41 | 0.66 | 0.84 | 0.64 | 0.00 |
| Current Ratio (X) | 7.36 | 7.29 | 5.44 | 8.43 | 9.60 |
| Quick Ratio (X) | 4.76 | 5.61 | 4.11 | 8.07 | 7.46 |
| Inventory Turnover Ratio (X) | 2.92 | 2.17 | 3.48 | 2.58 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 89.57 | 18.97 | 14.00 | 29.26 | 17.41 |
| Dividend Payout Ratio (CP) (%) | 39.30 | 16.01 | 13.43 | 26.61 | 16.05 |
| Earning Retention Ratio (%) | 10.43 | 81.03 | 86.00 | 70.74 | 82.59 |
| Cash Earning Retention Ratio (%) | 60.70 | 83.99 | 86.57 | 73.39 | 83.95 |
| Interest Coverage Ratio (X) | 25.34 | 129.35 | 402.75 | 278.96 | 366.92 |
| Interest Coverage Ratio (Post Tax) (X) | 9.69 | 82.43 | 290.61 | 196.48 | 279.45 |
| Enterprise Value (Cr.) | 265.36 | 454.53 | 366.00 | 225.38 | 226.11 |
| EV / Net Operating Revenue (X) | 3.71 | 4.37 | 3.31 | 3.41 | 3.60 |
| EV / EBITDA (X) | 30.81 | 18.01 | 6.28 | 9.45 | 8.17 |
| MarketCap / Net Operating Revenue (X) | 4.29 | 4.73 | 3.55 | 4.02 | 4.11 |
| Retention Ratios (%) | 10.42 | 81.02 | 85.99 | 70.73 | 82.58 |
| Price / BV (X) | 1.90 | 3.32 | 2.92 | 2.65 | 3.04 |
| Price / Net Operating Revenue (X) | 4.29 | 4.73 | 3.55 | 4.02 | 4.11 |
| EarningsYield | 0.01 | 0.03 | 0.10 | 0.06 | 0.08 |
After reviewing the key financial ratios for Diamines & Chemicals Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 2.79. This value is below the healthy minimum of 5. It has decreased from 16.24 (Mar 24) to 2.79, marking a decrease of 13.45.
- For Diluted EPS (Rs.), as of Mar 25, the value is 2.79. This value is below the healthy minimum of 5. It has decreased from 16.23 (Mar 24) to 2.79, marking a decrease of 13.44.
- For Cash EPS (Rs.), as of Mar 25, the value is 6.59. This value is within the healthy range. It has decreased from 19.15 (Mar 24) to 6.59, marking a decrease of 12.56.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 164.82. It has increased from 151.38 (Mar 24) to 164.82, marking an increase of 13.44.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 164.82. It has increased from 151.38 (Mar 24) to 164.82, marking an increase of 13.44.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 73.05. It has decreased from 106.33 (Mar 24) to 73.05, marking a decrease of 33.28.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 8.80. This value is within the healthy range. It has decreased from 25.79 (Mar 24) to 8.80, marking a decrease of 16.99.
- For PBIT / Share (Rs.), as of Mar 25, the value is 5.23. This value is within the healthy range. It has decreased from 22.88 (Mar 24) to 5.23, marking a decrease of 17.65.
- For PBT / Share (Rs.), as of Mar 25, the value is 4.88. This value is within the healthy range. It has decreased from 22.68 (Mar 24) to 4.88, marking a decrease of 17.80.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 3.02. This value is within the healthy range. It has decreased from 16.24 (Mar 24) to 3.02, marking a decrease of 13.22.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 2.79. This value is within the healthy range. It has decreased from 15.81 (Mar 24) to 2.79, marking a decrease of 13.02.
- For PBDIT Margin (%), as of Mar 25, the value is 12.04. This value is within the healthy range. It has decreased from 24.25 (Mar 24) to 12.04, marking a decrease of 12.21.
- For PBIT Margin (%), as of Mar 25, the value is 7.16. This value is below the healthy minimum of 10. It has decreased from 21.51 (Mar 24) to 7.16, marking a decrease of 14.35.
- For PBT Margin (%), as of Mar 25, the value is 6.68. This value is below the healthy minimum of 10. It has decreased from 21.33 (Mar 24) to 6.68, marking a decrease of 14.65.
- For Net Profit Margin (%), as of Mar 25, the value is 4.13. This value is below the healthy minimum of 5. It has decreased from 15.27 (Mar 24) to 4.13, marking a decrease of 11.14.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 3.82. This value is below the healthy minimum of 8. It has decreased from 14.87 (Mar 24) to 3.82, marking a decrease of 11.05.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.69. This value is below the healthy minimum of 15. It has decreased from 10.44 (Mar 24) to 1.69, marking a decrease of 8.75.
- For Return on Capital Employeed (%), as of Mar 25, the value is 3.08. This value is below the healthy minimum of 10. It has decreased from 14.69 (Mar 24) to 3.08, marking a decrease of 11.61.
- For Return On Assets (%), as of Mar 25, the value is 1.53. This value is below the healthy minimum of 5. It has decreased from 9.51 (Mar 24) to 1.53, marking a decrease of 7.98.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.41. It has decreased from 0.66 (Mar 24) to 0.41, marking a decrease of 0.25.
- For Current Ratio (X), as of Mar 25, the value is 7.36. This value exceeds the healthy maximum of 3. It has increased from 7.29 (Mar 24) to 7.36, marking an increase of 0.07.
- For Quick Ratio (X), as of Mar 25, the value is 4.76. This value exceeds the healthy maximum of 2. It has decreased from 5.61 (Mar 24) to 4.76, marking a decrease of 0.85.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 2.92. This value is below the healthy minimum of 4. It has increased from 2.17 (Mar 24) to 2.92, marking an increase of 0.75.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 89.57. This value exceeds the healthy maximum of 50. It has increased from 18.97 (Mar 24) to 89.57, marking an increase of 70.60.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 39.30. This value is within the healthy range. It has increased from 16.01 (Mar 24) to 39.30, marking an increase of 23.29.
- For Earning Retention Ratio (%), as of Mar 25, the value is 10.43. This value is below the healthy minimum of 40. It has decreased from 81.03 (Mar 24) to 10.43, marking a decrease of 70.60.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 60.70. This value is within the healthy range. It has decreased from 83.99 (Mar 24) to 60.70, marking a decrease of 23.29.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 25.34. This value is within the healthy range. It has decreased from 129.35 (Mar 24) to 25.34, marking a decrease of 104.01.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 9.69. This value is within the healthy range. It has decreased from 82.43 (Mar 24) to 9.69, marking a decrease of 72.74.
- For Enterprise Value (Cr.), as of Mar 25, the value is 265.36. It has decreased from 454.53 (Mar 24) to 265.36, marking a decrease of 189.17.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 3.71. This value exceeds the healthy maximum of 3. It has decreased from 4.37 (Mar 24) to 3.71, marking a decrease of 0.66.
- For EV / EBITDA (X), as of Mar 25, the value is 30.81. This value exceeds the healthy maximum of 15. It has increased from 18.01 (Mar 24) to 30.81, marking an increase of 12.80.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 4.29. This value exceeds the healthy maximum of 3. It has decreased from 4.73 (Mar 24) to 4.29, marking a decrease of 0.44.
- For Retention Ratios (%), as of Mar 25, the value is 10.42. This value is below the healthy minimum of 30. It has decreased from 81.02 (Mar 24) to 10.42, marking a decrease of 70.60.
- For Price / BV (X), as of Mar 25, the value is 1.90. This value is within the healthy range. It has decreased from 3.32 (Mar 24) to 1.90, marking a decrease of 1.42.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 4.29. This value exceeds the healthy maximum of 3. It has decreased from 4.73 (Mar 24) to 4.29, marking a decrease of 0.44.
- For EarningsYield, as of Mar 25, the value is 0.01. This value is below the healthy minimum of 5. It has decreased from 0.03 (Mar 24) to 0.01, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Diamines & Chemicals Ltd:
- Net Profit Margin: 4.13%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 3.08% (Industry Average ROCE: 10.57%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.69% (Industry Average ROE: 8.89%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 9.69
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 4.76
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 0 (Industry average Stock P/E: 33.43)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 4.13%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Others | Plot No. 13, PCC Area, Vadodra Gujarat 391350 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Amit Mehta | Executive Chairman |
| Mr. Rajendra Chhabra | Prof.Director |
| Mr. Tanmay Godiawala | Director |
| Mr. Dhruv Mehta | Independent Director |
| Mrs. Kejal Pandya | Independent Director |
| Mr. Priyam Jhaveri | Independent Director |
FAQ
What is the intrinsic value of Diamines & Chemicals Ltd?
Diamines & Chemicals Ltd's intrinsic value (as of 24 December 2025) is 33.88 which is 87.02% lower the current market price of 261.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 256 Cr. market cap, FY2025-2026 high/low of 515/250, reserves of ₹144.43 Cr, and liabilities of 177.50 Cr.
What is the Market Cap of Diamines & Chemicals Ltd?
The Market Cap of Diamines & Chemicals Ltd is 256 Cr..
What is the current Stock Price of Diamines & Chemicals Ltd as on 24 December 2025?
The current stock price of Diamines & Chemicals Ltd as on 24 December 2025 is 261.
What is the High / Low of Diamines & Chemicals Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Diamines & Chemicals Ltd stocks is 515/250.
What is the Stock P/E of Diamines & Chemicals Ltd?
The Stock P/E of Diamines & Chemicals Ltd is .
What is the Book Value of Diamines & Chemicals Ltd?
The Book Value of Diamines & Chemicals Ltd is 158.
What is the Dividend Yield of Diamines & Chemicals Ltd?
The Dividend Yield of Diamines & Chemicals Ltd is 0.38 %.
What is the ROCE of Diamines & Chemicals Ltd?
The ROCE of Diamines & Chemicals Ltd is 3.33 %.
What is the ROE of Diamines & Chemicals Ltd?
The ROE of Diamines & Chemicals Ltd is 1.78 %.
What is the Face Value of Diamines & Chemicals Ltd?
The Face Value of Diamines & Chemicals Ltd is 10.0.